رجوع
نطاق اليوم
KWD 116.74
KWD 120.12
نطاق 52 أسبوعًا
KWD 73.31
KWD 125.14
حجم التداول
6,937,576
متوسط 50 يوم / 200 يوم
KWD 115.65
/
KWD 94.64
الإغلاق السابق
KWD 116.37
Quick Summary
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (631 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 16.2 | 0.2 |
| P/B | 5.6 | 3.0 |
| ROE % | 36.9 | 3.6 |
| Net Margin % | 28.1 | 3.8 |
| Rev Growth 5Y % | 7.5 | 9.9 |
| D/E | 1.0 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 128.54
+7.7%
Low: KWD 100.00
High: KWD 150.00
مكرر الربحية المستقبلي
23.30
ربحية السهم المستقبلية
KWD 5.12
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
66.76B
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 10.16
KWD 9.87 – KWD 10.37
|
74.13B | 5 |
| FY2029 |
KWD 10.36
KWD 10.07 – KWD 10.58
|
74.56B | 2 |
| FY2028 |
KWD 10.77
KWD 8.85 – KWD 13.13
|
74.79B | 7 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-03 | KWD 2.01 | KWD 2.04 | +1.5% |
| 2025-10-30 | KWD 2.36 | KWD 2.58 | +9.3% |
| 2025-07-29 | KWD 2.03 | KWD 2.13 | +4.9% |
| 2025-04-24 | KWD 2.13 | KWD 2.22 | +4.2% |
| 2025-02-04 | KWD 1.85 | KWD 1.72 | -7.0% |
| 2024-10-31 | KWD 1.50 | KWD 1.57 | +4.7% |
| 2024-07-30 | KWD 2.15 | KWD 2.28 | +6.0% |
| 2024-04-25 | KWD 1.88 | KWD 2.07 | +10.1% |
Insider Trading Activity
Buy ratio (90d)
0.0%
15 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 6, 2026 |
DeLuca Richard R.
EVP&Pres, Merck Animal Heallth
|
sell | 37,685 | KWD 120.92 | KWD 4,557,024.71 |
| Feb 6, 2026 |
Oosthuizen Johannes Jacobus
President, U.S. Market
|
sell | 15,000 | KWD 121.87 | KWD 1,827,991.50 |
| Jan 26, 2026 |
Litchfield Caroline
EVP & CFO
|
grant | 15,852 | KWD 107.40 | KWD 1,702,504.80 |
| Jan 26, 2026 |
Guindo Chirfi
Chief Marketing Officer
|
grant | 9,865 | KWD 107.40 | KWD 1,059,501.00 |
| Jan 26, 2026 |
Li Dean Y
Executive VP & President, MRL
|
grant | 20,469 | KWD 107.40 | KWD 2,198,370.60 |
| Jan 26, 2026 |
Davis Robert M
Chairman, CEO & President
|
grant | 47,434 | KWD 107.40 | KWD 5,094,411.60 |
| Dec 31, 2025 |
Seidman Christine E
Director
|
grant | 77 | KWD 105.26 | KWD 8,105.02 |
| Nov 10, 2025 |
Downing Cristal N
Chief Comm. & Public Afrs Ofcr
|
sell | 7,085 | KWD 87.00 | KWD 616,395.00 |
| Sep 30, 2025 |
Coe Mary Ellen
Director
|
grant | 357 | KWD 83.93 | KWD 29,963.01 |
| Sep 30, 2025 |
Seidman Christine E
Director
|
grant | 97 | KWD 83.93 | KWD 8,141.21 |
| Jun 30, 2025 |
GLOCER THOMAS H
Director
|
grant | 616 | KWD 79.16 | KWD 48,762.56 |
| Jun 30, 2025 |
Seidman Christine E
Director
|
grant | 103 | KWD 79.16 | KWD 8,153.48 |
| May 30, 2025 |
Craig Pamela J.
Director
|
grant | 2,863 | KWD 76.84 | KWD 219,992.92 |
| May 30, 2025 |
Seidman Christine E
Director
|
grant | 2,863 | KWD 76.84 | KWD 219,992.92 |
| Mar 31, 2025 |
Seidman Christine E
Director
|
grant | 91 | KWD 89.76 | KWD 8,168.16 |
Dividend History
7 yr streakYield
0.03%
Payout Ratio
0.45%
Growth (3Y)
5.42%
Growth (5Y)
5.75%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 16, 2026 | Apr 07, 2026 | KWD 0.85 | 2.88% |
| Dec 15, 2025 | Jan 08, 2026 | KWD 0.85 | 3.27% |
| Sep 15, 2025 | Oct 07, 2025 | KWD 0.81 | 4.00% |
| Jun 16, 2025 | Jul 08, 2025 | KWD 0.81 | 3.95% |
| Mar 17, 2025 | Apr 07, 2025 | KWD 0.81 | 3.33% |
| Dec 16, 2024 | Jan 08, 2025 | KWD 0.81 | 3.12% |
| Sep 16, 2024 | Oct 07, 2024 | KWD 0.77 | 2.61% |
| Jun 17, 2024 | Jul 08, 2024 | KWD 0.77 | 2.38% |
| Mar 14, 2024 | Apr 05, 2024 | KWD 0.77 | 2.49% |
| Dec 14, 2023 | Jan 08, 2024 | KWD 0.77 | 2.80% |
| Sep 14, 2023 | Oct 06, 2023 | KWD 0.73 | 2.70% |
| Jun 14, 2023 | Jul 10, 2023 | KWD 0.73 | 2.65% |
| Mar 14, 2023 | Apr 10, 2023 | KWD 0.73 | 2.65% |
| Dec 14, 2022 | Jan 09, 2023 | KWD 0.73 | 2.51% |
| Sep 14, 2022 | Oct 07, 2022 | KWD 0.69 | 3.17% |
| Jun 14, 2022 | Jul 08, 2022 | KWD 0.69 | 3.22% |
| Mar 14, 2022 | Apr 07, 2022 | KWD 0.69 | 3.45% |
| Dec 14, 2021 | Jan 07, 2022 | KWD 0.69 | 3.54% |
| Sep 14, 2021 | Oct 07, 2021 | KWD 0.65 | 3.52% |
| Jun 14, 2021 | Jul 07, 2021 | KWD 0.65 | 3.28% |
النقاط الرئيسية
Revenue grew 7.49% annually over 5 years — modest growth
ROE of 36.91% indicates high profitability
Net margin of 28.08% shows strong profitability
Generating 12.36B in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 6.18%
Capital efficient — spends only 6.33% of revenue on capex
النمو
Revenue Growth (5Y)
7.49%
Revenue (1Y)1.31%
Earnings (1Y)6.64%
FCF Growth (3Y)16.27%
الجودة
Return on Equity
36.91%
ROIC19.47%
Net Margin28.08%
Op. Margin41.19%
الأمان
Debt / Equity
0.96
Current Ratio1.54
Interest Coverage0.00
التقييم
P/E Ratio
16.17
Forward P/E23.30
P/B Ratio5.61
EV/EBITDA12.36
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1.31% | Revenue Growth (3Y) | 3.99% |
| Earnings Growth (1Y) | 6.64% | Earnings Growth (3Y) | 607.18% |
| Revenue Growth (5Y) | 7.49% | Earnings Growth (5Y) | 8.75% |
| Profitability | |||
| Revenue (TTM) | 65.01B | Net Income (TTM) | 18.25B |
| ROE | 36.91% | ROA | 13.34% |
| Gross Margin | 81.50% | Operating Margin | 41.19% |
| Net Margin | 28.08% | Free Cash Flow (TTM) | 12.36B |
| ROIC | 19.47% | FCF Growth (3Y) | 16.27% |
| Safety | |||
| Debt / Equity | 0.96 | Current Ratio | 1.54 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 0.03% | Payout Ratio | 0.45% |
| Dividend Growth (3Y) | 5.42% | Dividend Growth (5Y) | 5.75% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 16.17 | Forward P/E | 23.30 |
| P/B Ratio | 5.61 | P/S Ratio | 4.54 |
| PEG Ratio | 1.88 | Forward PEG | N/A |
| EV/EBITDA | 12.36 | Fwd EV/EBITDA | 11.51 |
| Forward P/S | 4.42 | Fwd Earnings Yield | 4.29% |
| FCF Yield | 4.19% | ||
| Market Cap | 295.13B | Enterprise Value | 331.10B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 65.01B | 64.17B | 60.12B | 59.28B | 48.70B |
| Net Income | 18.25B | 17.12B | 365.00M | 14.52B | 13.05B |
| EPS (Diluted) | 7.28 | 6.74 | 0.14 | 5.71 | 5.14 |
| Gross Profit | 52.98B | 48.98B | 43.99B | 41.87B | 35.08B |
| Operating Income | 26.78B | 20.22B | 2.95B | 18.28B | 13.20B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 136.87B | 117.11B | 106.68B | 109.16B | 105.69B |
| Total Liabilities | 84.20B | 70.73B | 69.04B | 63.10B | 67.44B |
| Shareholders' Equity | 52.61B | 46.31B | 37.58B | 45.99B | 38.18B |
| Total Debt | 50.53B | 38.27B | 36.27B | 31.99B | 34.63B |
| Cash & Equivalents | 14.57B | 13.24B | 6.84B | 12.69B | 8.10B |
| Current Assets | 43.52B | 38.78B | 32.17B | 35.72B | 30.27B |
| Current Liabilities | 28.33B | 28.42B | 25.69B | 24.24B | 23.87B |